v3.26.3
Condensed Consolidated Statements of Changes In Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balances at Dec. 31, 2024 $ 2 $ 908,523 $ (899,683) $ (5) $ 8,837
Balance, shares at Dec. 31, 2024 22,546,671        
Vesting of restricted stock units
Vesting of restricted stock units, shares 87,419          
Tax withholding on vesting of restricted stock units (98) (98)
Issuance to Dragasac in connection with warrant repricing 2,460 2,460
Issuance to Dragasac in connection with warrant repricing, shares 1,188,255          
Dragasac Warrant Issuance Inducement 64 (64)
Issuance of common stock consideration shares to Yorkville in connection with Side Letter 149 149
Issuance of common stock consideration shares to Yorkville in connection with Side Letter, shares 100,000          
Issuance of common stock in connection with settlement of debt 51 51
Issuance of common stock in connection with settlement of debt, shares 21,739          
Issuance and modification of warrants to C. V. Starr 207 207
Change in fair value of debt 5 5
Stock-based compensation expense 2,637 2,637
Net income (loss) (19,754) (19,754)
Balances at Mar. 31, 2025 $ 2 913,993 (919,501) (5,506)
Balance, shares at Mar. 31, 2025 23,944,084        
Balances at Dec. 31, 2024 $ 2 908,523 (899,683) (5) 8,837
Balance, shares at Dec. 31, 2024 22,546,671        
Net income (loss)           (44,278)
Series A Convertible Preferred Share Conversion to the Exchange Promissory Note          
Balances at Jun. 30, 2025 $ 2 918,529 (944,025) (3) (25,497)
Balance, shares at Jun. 30, 2025 24,610,151        
Balances at Dec. 31, 2024 $ 2 908,523 (899,683) (5) 8,837
Balance, shares at Dec. 31, 2024 22,546,671        
Issuance of common stock due to Strategic Advisory Agreement, shares 50,000          
Balances at Dec. 31, 2025 $ 3 953,418 (991,483) (38,062)
Balance, shares at Dec. 31, 2025 28,837,787 1,732,084        
Balances at Mar. 31, 2025 $ 2 913,993 (919,501) (5,506)
Balance, shares at Mar. 31, 2025 23,944,084        
Vesting of restricted stock units
Vesting of restricted stock units, shares 13,435          
Tax withholding on vesting of restricted stock units (14) (14)
Issuance of common stock consideration shares to Yorkville in connection with Side Letter 233 233
Issuance of common stock consideration shares to Yorkville in connection with Side Letter, shares 100,000          
Issuance of common stock in connection with settlement of debt 21 21
Issuance of common stock in connection with settlement of debt, shares 12,000          
Change in fair value of debt (3) (3)
Stock-based compensation expense 2,448 2,448
Net income (loss) (24,524) (24,524)
Common stock issued pursuant to short—term debt conversion 922 922
Conversion of Madison Global Partners convertible note, shares 490,632          
Issuance of common stock in exchange for consulting services 108 108
Issuance of equity-classified warrants 317 317
Reclassification of liability-classified warrants to equity-classified warrants 501 501
Balances at Jun. 30, 2025 $ 2 918,529 (944,025) (3) (25,497)
Balance, shares at Jun. 30, 2025 24,610,151        
Balances at Dec. 31, 2025 $ 3 953,418 (991,483) (38,062)
Balance, shares at Dec. 31, 2025 28,837,787 1,732,084        
Vesting of restricted stock units
Vesting of restricted stock units, shares 9,711          
Stock-based compensation expense 1,243 1,243
Net income (loss) 874 874
Issuance of warrants for Strategic Advisory Services 256 256
Issuance of common stock in connection with legal settlement 300 300
Issuance of common stock in connection with legal settlement, shares 233,790          
Director fees paid with restricted stock units 128 128
Director fees paid with restricted stock units, shares 98,463          
Balances at Mar. 31, 2026 $ 3 955,345 (990,609) (35,261)
Balance, shares at Mar. 31, 2026 29,179,751 1,732,084        
Balances at Dec. 31, 2025 $ 3 953,418 (991,483) (38,062)
Balance, shares at Dec. 31, 2025 28,837,787 1,732,084        
Net income (loss)           1,580
Series A Convertible Preferred Share Conversion to the Exchange Promissory Note           (1,942)
Balances at Jun. 30, 2026 $ 3 954,369 (989,903) (35,531)
Balance, shares at Jun. 30, 2026 29,283,614        
Balances at Mar. 31, 2026 $ 3 955,345 (990,609) (35,261)
Balance, shares at Mar. 31, 2026 29,179,751 1,732,084        
Vesting of restricted stock units
Vesting of restricted stock units, shares 3,863          
Stock-based compensation expense 844 844
Net income (loss) 706 706
Issuance of warrants for Strategic Advisory Services 49 49
Issuance of common stock in connection with legal settlement 73 73
Issuance of common stock in connection with legal settlement, shares 100,000          
Series A Convertible Preferred Share Conversion to the Exchange Promissory Note (1,942) (1,942)
Series A Convertible Preferred Share Conversion to the Exchange Promissory Note, shares   (1,732,084)        
Balances at Jun. 30, 2026 $ 3 $ 954,369 $ (989,903) $ (35,531)
Balance, shares at Jun. 30, 2026 29,283,614